State Street’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$159M Buy
3,270,596
+859,334
+36% +$41.8M 0.01% 1048
2025
Q1
$82.1M Sell
2,411,262
-80,263
-3% -$2.73M ﹤0.01% 1381
2024
Q4
$98.1M Sell
2,491,525
-501,463
-17% -$19.7M ﹤0.01% 1345
2024
Q3
$141M Buy
2,992,988
+599,304
+25% +$28.2M 0.01% 1124
2024
Q2
$129M Buy
2,393,684
+898,476
+60% +$48.5M 0.01% 1106
2024
Q1
$102M Sell
1,495,208
-258,289
-15% -$17.6M ﹤0.01% 1292
2023
Q4
$110M Sell
1,753,497
-131,476
-7% -$8.23M 0.01% 1233
2023
Q3
$85.6M Buy
1,884,973
+252,500
+15% +$11.5M ﹤0.01% 1286
2023
Q2
$91.6M Sell
1,632,473
-353,714
-18% -$19.9M ﹤0.01% 1281
2023
Q1
$89.8M Sell
1,986,187
-94,929
-5% -$4.29M 0.01% 1258
2022
Q4
$84.6M Buy
2,081,116
+512,732
+33% +$20.8M 0.01% 1274
2022
Q3
$102M Sell
1,568,384
-1,476
-0.1% -$96.5K 0.01% 1095
2022
Q2
$95.4M Buy
1,569,860
+1,092,384
+229% +$66.4M 0.01% 1186
2022
Q1
$30M Buy
477,476
+269,824
+130% +$16.9M ﹤0.01% 2109
2021
Q4
$15.7M Buy
207,652
+45,010
+28% +$3.41M ﹤0.01% 2643
2021
Q3
$18.2M Buy
162,642
+11,726
+8% +$1.31M ﹤0.01% 2540
2021
Q2
$24.4M Buy
150,916
+1,661
+1% +$269K ﹤0.01% 2388
2021
Q1
$18.2M Buy
149,255
+13,894
+10% +$1.69M ﹤0.01% 2416
2020
Q4
$20.7M Sell
135,361
-5,950
-4% -$911K ﹤0.01% 2222
2020
Q3
$11.8M Buy
141,311
+20,522
+17% +$1.72M ﹤0.01% 2352
2020
Q2
$8.88M Buy
120,789
+49,578
+70% +$3.64M ﹤0.01% 2486
2020
Q1
$3.02M Buy
71,211
+23,159
+48% +$982K ﹤0.01% 2870
2019
Q4
$2.93M Buy
48,052
+10,949
+30% +$667K ﹤0.01% 3101
2019
Q3
$1.52M Buy
37,103
+758
+2% +$31.1K ﹤0.01% 3300
2019
Q2
$1.71M Buy
36,345
+10,292
+40% +$485K ﹤0.01% 3295
2019
Q1
$931K Sell
26,053
-300
-1% -$10.7K ﹤0.01% 3349
2018
Q4
$753K Sell
26,353
-1,117
-4% -$31.9K ﹤0.01% 3381
2018
Q3
$1.22M Buy
27,470
+3,337
+14% +$148K ﹤0.01% 3375
2018
Q2
$1.42M Buy
+24,133
New +$1.42M ﹤0.01% 3356